Established 1999
 
8,000 companies from
USA,Canada and India.		  
   
Search over 25,000 News & Earnings Archives    
 
  Quotes Find Symbol:
 Company Links
1020 East Meadow Circle
Palo Alto, CA 94303
USA
+1-650-687-3900
http://www.alexza.com
 Management    Source: Company documents
Name : Thomas B. King
Title : President, Chief Executive Officer, Director
Since: 06/2003
Name : August J. Moretti
Title : Chief Financial Officer, Senior Vice President, Secretary
Since: 02/2005
Name : James V. Cassella
Title : Senior Vice President, Research and Development
Since: 06/2004
Name : Anthony G. Tebbutt
Title : Senior Vice President - Corporate Strategy and Business Development
Since: 03/14/2007
Name : Robert S. Fishman
Title : Vice President, Medical Affairs
Since: 09/2007
Name : Emily L. Kelley
Title : Vice President - Human Resources
Since: 10/2002
Name : Joseph Baker
Title : Vice President - Commercial Manufacturing & Global Supply Chain
Since: 11/2006
Name : Nasrat Hakim
Title : Vice President - Quality
Since: 07/18/2007
Name : Michael J. Simms
Title : Senior Vice President, Operations and Manufacturing
Since: 02/2008
Name : William L. Leschensky
Title : Vice President, Intellectual Property
Since: 11/2005
Name : Michael Taylor
Title : Vice President, Preclinical Development
Since: 08/2006
 Earnings Calls
Earnings Release Dates : 6th August 2008 , 12th May 2008 , 17th March 2008 , 1st November 2007
Audio
 Annual Reports
 Quarterly Earnings - ALXA
Sequential Earnings Growth | Quarterly Earnings by Year | Quarterly Earnings Growth by Year

Source: Company filings    Q1:March  Q2:June  Q3:September  Q4:December
 Annual Earnings - ALXA
Annual earnings growth

Diluted EPS Excluding Extraordinary Items     Source: Company filings
 123JUMP News:
NYSE Goes Public   Mar 12, 3:47 PM EST
 IPO Reports:
Alexza Pharmaceuticals
The Company has one product candidate that has completed a Phase IIa clinical trial and two product candidates that have each completed a Phase I clinical trial, and it filed an IND for an additional product candidate in February 2006. The Company is developing AZ-001 for the treatment of acute migraine headaches. The API of AZ-001 is prochlorperazine, a drug belonging to the class of drugs known as phenothiazines.
More...




   
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
© 1999-2008 123jump.com. All rights reserved   
 

Warning: Unknown: Your script possibly relies on a session side-effect which existed until PHP 4.2.3. Please be advised that the session extension does not consider global variables as a source of data, unless register_globals is enabled. You can disable this functionality and this warning by setting session.bug_compat_42 or session.bug_compat_warn to off, respectively. in Unknown on line 0